RGEN May 2024 180.000 call
| Previous close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 180.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GlobeNewswireRepligen Corporation to Present at Upcoming May Investor Conferences
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2024 Global Healthcare Conference, being held in New York on May 14-15. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 14, 2024 at 10:30 a.m. ET, in addition to a series of
Simply Wall St.Repligen First Quarter 2024 Earnings: EPS Misses Expectations
Repligen ( NASDAQ:RGEN ) First Quarter 2024 Results Key Financial Results Revenue: US$151.3m (down 17% from 1Q 2023...
Insider MonkeyRepligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript May 1, 2024 Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29. Repligen Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, […]
